greeksoup/ stock research
Stock research / United States / ZBH / FY2007

Zimmer Biomet Holdings (ZBH) FY2007 results: revenue $3.9 billion

Zimmer Biomet Holdings, Inc. (ZBH) reported revenue of $3.9 billion for fiscal 2007, the year ended 31 December 2007. Net income was $773 million, and diluted earnings per share $3.26. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2010.

Revenue
$3.9 billion
FY2007FY2007
Operating margin
28.9%
FY2007FY2007
Net income
$773 million
FY2007FY2007
Diluted EPS
$3.26
FY2007FY2007

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2007Last 8 years
Revenue3,898
Cost of revenue876
Gross profit3,022
Gross margin77.5%
Research and development183
Selling, general and administrative1,517
Operating income1,128
Operating margin28.9%
Pre-tax income1,132
Income tax358
Effective tax rate31.6%
Net income773
Net margin19.8%
Diluted EPS$3.26
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2007Last 8 years
Operating cash flow1,084
Capital expenditure193
Free cash flow892
Free cash flow margin22.9%
Cash from investing-492
Cash from financing-400
Depreciation and amortisation230
Share-based compensation70.1
Buybacks576
Diluted shares, weighted238m

Balance sheet

$ millionFY2007Last 8 years
Shareholders' equity5,452
Cash and equivalents464

10-K for the year ended 31 December 2007, filed 25 February 2010: the filing.